The CI discipline continues to grow and add value, yet still faces key challenges in education, delivery and executive share of voice

Dr. Mark Little

Senior Vice President, Intelligence & Insight

Competitive intelligence (CI) is fundamental to ensuring the success of pharmaceutical companies, whether they are planning a new drug or are already an established presence in the market. Alongside research and development (R&D), CI is crucial to businesses that want to maximize the value of their science.

Prescient’s industry study of CI professionals is now in its third year – and bigger than ever. Exploring the present state of play and current challenges, as well as looking to future strategies and desired outcomes, the survey is an important landmark on the CI calendar.

Join Mark Little, Senior Vice President, Intelligence & Insight, on Tuesday, September 28, 2021 | 11:00 AM EDT, as he previews the key research findings of the Prescient Competitive Intelligence Report 2021 prior to its full publication.

During this webinar, you will learn:

  • The highlights of the top ten challenges for CI professionals in 2021
  • How the landscape has changed since our previous survey in 2020
  • Strategies and responses appropriate for a post-COVID-19 world

Attending the session live will allow you the opportunity to share your questions with Mark and be among the first to receive a complimentary copy of the Prescient Competitive Intelligence Report 2021.

To reserve your place, please register using the following form.